Relationship Between MAFLD and Liver Fibrosis Progression in Patients With Chronic Hepatitis B: a Multicenter Retrospective Cohort Study
NCT05708560 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800
Last updated 2023-02-01
Summary
This multicenter retrospective study aims to study the association between the presence of MAFLD and change in liver stiffness over time in untreated and treated patients with chronic hepatitis B
Conditions
- Hepatitis B, Chronic
Sponsors & Collaborators
- lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-01
- Primary Completion
- 2023-01-31
- Completion
- 2023-01-31
Countries
- Netherlands
Study Locations
More Related Trials
-
MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B
NCT06779058 ·Status: RECRUITING
-
Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver Disease
NCT02658786 ·Status: WITHDRAWN
-
Role of Regulatory B Cells in the Pathogenesis of Metabolic Associated Fatty Liver Disease
NCT04720560 ·Status: RECRUITING
-
Frequency of Metabolic Dysfunction Associated Fatty Liver Disease in Patients With Acute Coronary Syndromes
NCT06456970 ·Status: NOT_YET_RECRUITING
-
Clinical Correlation Evaluation of the LIVERFASt Test for Diagnosing Important Liver Lesions of Fibrosis and Steatosis Against Magnetic Resonance Elastography (MRE) for Liver Fibrosis and MR-based Assessment of Steatosis, in Adult US Population.
NCT06797596 ·Status: NOT_YET_RECRUITING
-
Identification of Hepatic Fibrosis Using 4D-MRI
NCT05385237 ·Status: RECRUITING ·Phase: NA
-
Steatohepatitis in Chronic Hepatitis B
NCT05317260 ·Status: COMPLETED
-
NAFLD Primary Care
NCT04918732 ·Status: RECRUITING ·Phase: NA
-
Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD
NCT04774302 ·Status: COMPLETED
-
NMR-based Metabolic Profiling Identifies High Risk of MAFLD Patients With Advanced Fibrosis
NCT05734599 ·Status: UNKNOWN
-
Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD
NCT05766449 ·Status: RECRUITING
-
Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study
NCT05974904 ·Status: RECRUITING
-
Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozygous Familial Hypercholesterolemia
NCT06634160 ·Status: RECRUITING
-
Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients
NCT06814600 ·Status: RECRUITING
-
NASH: Non-invasive Diagnostic Markers and Imaging
NCT02717000 ·Status: UNKNOWN
-
The European NAFLD Registry
NCT04442334 ·Status: RECRUITING
-
Evaluation of Patients With Liver Disease
NCT00001971 ·Status: RECRUITING
-
Identification of Biomarkers Related to Liver Fibrosis as New Therapeutic Targets
NCT03979417 ·Status: COMPLETED
-
Steatosis Assessment Pre-LDLT
NCT07015723 ·Status: ENROLLING_BY_INVITATION
-
Study Visceral Adipose Tissue and Liver Stifness in a Retrospective Cohort of Diabetes Mellitus Patients
NCT04493814 ·Status: UNKNOWN
-
Hepatic Steatosis and Chronic Hepatitis B Virus
NCT05678582 ·Status: COMPLETED
-
Evaluation of Liver Fibrosis With 2D-Shear Wave Elastography
NCT04759521 ·Status: COMPLETED
-
Impact of Muscle Insulin Resistance on the Pathogenesis of Non Alcoholic Steatohepatitis
NCT01324414 ·Status: COMPLETED
-
Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology.
NCT04435054 ·Status: COMPLETED ·Phase: NA
-
To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease
NCT07149571 ·Status: RECRUITING